Hyper,
We are on the same page on NWBO, I was being facetious.
Readout there is coming in a couple months.
It will be great news for CYRX, because I believe it will be frontline treatment for GBM, especially with its safety profile.
Then, we have Direct, which is for all solid cancers.
Maybe NWBO will end up buying CYRX.....being facetious again, but the sooner this gets to market, the better for patients, and longs of both stocks.
News 
Market Data 
Discover 
